Home
 Search
 Category
 Compounds
 Status
 Download
 Contacts
 Resources


Compound category: Organoheterocyclic compounds
(total 322 related compounds in database, current show from 51 to 60)
 
Compound name 2D structure Target pathogen(s) Related VF/VFcategory Max phase Reference(s)
SYG-180-2-2
(internal name in literature)		 Depiction based on curated SMILES Se O N H HN Staphylococcus β-hemolysin Preclinical (in vivo) Rao L, et al. 2021. Front Microbiol; Rao L, et al. 2022. Front Cell Infect Microbiol
YH7
(internal name in literature)		 Depiction based on curated SMILES O Se Se O N Staphylococcus Biofilm Preclinical (in vivo) Xiao Y, et al. 2024. mSphere
(5R,6R)-5,6-bis[(4-benzyltriazol-1-yl)methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-2-amine Depiction based on curated SMILES N H N N N N N H N H N H 2 N Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-butyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N N N H 2 N N H N N H 3 C N H 3 C H H N Acinetobacter Biofilm Preclinical (in vitro) Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-cyclohexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N H N N N N N H N N H NH 2 Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-cyclopentyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N H N N N N NH N N H NH 2 Acinetobacter
Staphylococcus		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-heptyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES H 3 C N N N HN H 2 N N N N N H 3 C H H Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-hexyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES H 3 C N N N N H H 2 N N N N N H 3 C H H Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-pentyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N N H 3 C N HN H 2 N N N N N H 3 C H H Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
5beta,6alpha-Bis(4-phenyl-1H-1,2,3-triazole-1-ylmethyl)-4,5,6,7-tetrahydro-1H-benzoimidazole-2-amine Depiction based on curated SMILES N H N N N N N H N N H NH 2 Acinetobacter
Pseudomonas		 Biofilm
Biofilm		 Preclinical (in vitro)
Preclinical (in vitro)		 Huigens RW 3rd, et al. 2009. Org Biomol Chem
   


NOTE: for more interactive and statistic charts, please visit the JavaScript-rich interface of VFDB.



Page  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  ...  33



Back to top
2004-2024 NIPB, CAMS&PUMC